No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4um9D, 0.9728, 0.86, 0.117, 455, 240, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
2, 4um9B, 0.9723, 0.86, 0.117, 448, 240, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
3, 3fcsD, 0.9701, 0.94, 0.108, 603, 240, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
4, 3fcsB, 0.9696, 0.95, 0.108, 680, 240, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
5, 3zdxB, 0.9676, 0.99, 0.108, 464, 240, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
6, 4g1mB, 0.9675, 0.98, 0.108, 692, 240, RE-REFINEMENT OF ALPHA V BETA 3 STRUCTURE
7, 3zdxD, 0.9673, 1.00, 0.108, 469, 240, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
8, 3t3mD, 0.9672, 1.00, 0.108, 471, 240, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
9, 3t3mB, 0.9672, 1.00, 0.108, 466, 240, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
10, 3nidB, 0.9672, 0.99, 0.108, 466, 240, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
11, 3t3pB, 0.9671, 1.00, 0.108, 466, 240, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
12, 4um8B, 0.9668, 1.05, 0.117, 423, 240, CRYSTAL STRUCTURE OF ALPHA V BETA 6
13, 3zdyB, 0.9668, 1.01, 0.108, 464, 240, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
14, 3nifB, 0.9668, 1.01, 0.108, 466, 240, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
15, 3nidD, 0.9668, 1.00, 0.108, 471, 240, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
16, 3zdyD, 0.9667, 1.01, 0.108, 469, 240, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
17, 3nifD, 0.9667, 1.01, 0.108, 467, 240, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
18, 3t3pD, 0.9666, 1.01, 0.108, 471, 240, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
19, 4z7qB, 0.9665, 1.01, 0.108, 466, 240, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
20, 4mmzB, 0.9665, 0.99, 0.108, 690, 240, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO AN ANTAGONISTIC TENTH DOMAIN OF FIBRONECTIN
21, 5ffgB, 0.9664, 1.05, 0.117, 248, 240, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 6 HEAD
22, 4g1eB, 0.9664, 1.01, 0.108, 709, 240, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.
23, 3nigB, 0.9664, 1.01, 0.108, 466, 240, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
24, 4z7nD, 0.9663, 1.02, 0.108, 469, 240, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
25, 3nigD, 0.9662, 1.02, 0.108, 471, 240, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
26, 3zdzD, 0.9661, 1.02, 0.108, 469, 240, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
27, 4z7qD, 0.9657, 1.03, 0.108, 471, 240, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
28, 4um8D, 0.9656, 1.07, 0.117, 414, 240, CRYSTAL STRUCTURE OF ALPHA V BETA 6
29, 5hdbB, 0.9653, 1.04, 0.108, 466, 240, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
30, 3ze0D, 0.9652, 1.03, 0.108, 469, 240, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
31, 4z7oD, 0.9651, 1.05, 0.108, 469, 240, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
32, 5hdbD, 0.9648, 1.04, 0.108, 471, 240, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
33, 3ze1D, 0.9638, 1.06, 0.108, 469, 240, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
34, 5netB, 0.9636, 0.88, 0.113, 448, 238, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE A.
35, 5nerB, 0.9636, 0.88, 0.113, 448, 238, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A PRIME.
36, 5nemB, 0.9636, 0.88, 0.113, 448, 238, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A.
37, 3v4pD, 0.9636, 1.01, 0.121, 375, 239, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
38, 3v4pB, 0.9636, 1.01, 0.121, 375, 239, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
39, 3v4vD, 0.9634, 1.01, 0.121, 375, 239, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
40, 3v4vB, 0.9634, 1.01, 0.121, 375, 239, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
41, 4z7oB, 0.9629, 1.09, 0.108, 464, 240, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
42, 1jv2B, 0.9627, 0.98, 0.113, 539, 239, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3
43, 4o02B, 0.9622, 1.09, 0.108, 687, 240, ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.
44, 3ze2B, 0.9622, 1.10, 0.108, 469, 240, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
45, 4wk0B, 0.9621, 0.83, 0.118, 427, 237, METAL ION AND LIGAND BINDING OF INTEGRIN
46, 3ijeB, 0.9612, 1.03, 0.113, 695, 239, CRYSTAL STRUCTURE OF THE COMPLETE INTEGRIN ALHAVBETA3 ECTODOMAIN PLUS AN ALPHA/BETA TRANSMEMBRANE FRAGMENT
47, 3vi3D, 0.9611, 0.82, 0.118, 432, 237, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
48, 3vi4D, 0.9610, 0.83, 0.118, 433, 237, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
49, 3vi3B, 0.9610, 0.85, 0.118, 427, 237, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
50, 1m1xB, 0.9610, 1.02, 0.113, 539, 239, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+
51, 4wk4B, 0.9606, 0.87, 0.118, 435, 237, METAL ION AND LIGAND BINDING OF INTEGRIN
52, 1u8cB, 0.9606, 1.03, 0.113, 599, 239, A NOVEL ADAPTATION OF THE INTEGRIN PSI DOMAIN REVEALED FROM ITS CRYSTAL STRUCTURE
53, 4wk2B, 0.9605, 0.88, 0.118, 427, 237, METAL ION AND LIGAND BINDING OF INTEGRIN
54, 3vi4B, 0.9604, 0.85, 0.118, 431, 237, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
55, 4wjkB, 0.9602, 0.85, 0.118, 424, 237, METAL ION AND LIGAND BINDING OF INTEGRIN
56, 5e6uB, 0.9587, 0.95, 0.109, 453, 238, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
57, 5e6sD, 0.9578, 0.98, 0.109, 455, 238, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
58, 5e6rB, 0.9577, 0.98, 0.109, 454, 238, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
59, 5e6sF, 0.9575, 0.98, 0.109, 455, 238, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
60, 4nenB, 0.9571, 1.00, 0.109, 665, 238, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
61, 5e6sB, 0.9555, 1.02, 0.109, 455, 238, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
62, 6avrB, 0.9539, 1.24, 0.108, 685, 240, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
63, 6avqB, 0.9539, 1.24, 0.108, 688, 240, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
64, 5es4F, 0.9533, 1.06, 0.109, 674, 238, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
65, 6avuB, 0.9522, 1.28, 0.108, 461, 240, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
66, 5es4B, 0.9506, 1.11, 0.109, 674, 238, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
67, 5es4H, 0.9484, 1.15, 0.109, 674, 238, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
68, 5es4D, 0.9468, 1.17, 0.109, 674, 238, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
69, 5neuB, 0.9462, 1.40, 0.117, 448, 239, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE B.
70, 3k71D, 0.9454, 1.19, 0.109, 673, 238, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
71, 3k71F, 0.9453, 1.19, 0.109, 673, 238, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
72, 3k71B, 0.9453, 1.19, 0.109, 673, 238, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
73, 3k6sF, 0.9453, 1.19, 0.109, 674, 238, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
74, 3k6sB, 0.9453, 1.19, 0.109, 674, 238, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
75, 3k71H, 0.9452, 1.19, 0.109, 673, 238, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
76, 3k6sH, 0.9451, 1.20, 0.109, 674, 238, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
77, 3k6sD, 0.9451, 1.20, 0.109, 674, 238, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
78, 3k72D, 0.9450, 1.19, 0.109, 673, 238, STRUCTURE OF INTEGRIN ALPHAX BETA2
79, 3k72B, 0.9450, 1.20, 0.109, 673, 238, STRUCTURE OF INTEGRIN ALPHAX BETA2
80, 4z7nB, 0.9435, 1.77, 0.108, 464, 240, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
81, 3zdzB, 0.9423, 1.77, 0.108, 464, 240, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
82, 4nehB, 0.9422, 1.28, 0.109, 668, 238, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
83, 3ze1B, 0.9421, 1.77, 0.108, 464, 240, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
84, 3ze0B, 0.9419, 1.78, 0.108, 465, 240, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
85, 1l5gB, 0.9402, 1.41, 0.113, 539, 239, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGAND
86, 4mmyB, 0.9394, 1.70, 0.108, 690, 240, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF
87, 4mmxB, 0.9385, 1.75, 0.108, 690, 240, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN
88, 5ffoF, 0.9206, 1.62, 0.097, 242, 237, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
89, 5ffoB, 0.9205, 1.62, 0.097, 242, 237, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
90, 1tyeD, 0.9106, 1.70, 0.093, 440, 236, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
91, 3ze2D, 0.9103, 1.70, 0.093, 367, 236, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
92, 3fcuF, 0.9103, 1.70, 0.093, 455, 236, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
93, 3fcuD, 0.9101, 1.71, 0.093, 455, 236, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
94, 3fcuB, 0.9099, 1.71, 0.093, 455, 236, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
95, 1tyeB, 0.9094, 1.72, 0.093, 440, 236, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
96, 1tyeF, 0.9084, 1.73, 0.093, 440, 236, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
97, 2vdrB, 0.9069, 1.76, 0.093, 455, 236, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
98, 2vdoB, 0.9068, 1.76, 0.093, 455, 236, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
99, 2vc2B, 0.9068, 1.77, 0.093, 457, 236, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
100, 2vdkB, 0.9067, 1.76, 0.093, 455, 236, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
101, 2vdqB, 0.9066, 1.77, 0.093, 455, 236, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
102, 2vdpB, 0.9066, 1.76, 0.093, 455, 236, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
103, 2vdlB, 0.9063, 1.77, 0.093, 456, 236, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
104, 2vdnB, 0.9061, 1.78, 0.093, 455, 236, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
105, 2vdmB, 0.9061, 1.77, 0.093, 456, 236, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
106, 6djpB, 0.8893, 1.18, 0.130, 353, 223, INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS 8B8 AND 68 
107, 2iueA, 0.7997, 1.59, 0.097, 212, 206, PACTOLUS I-DOMAIN: FUNCTIONAL SWITCHING OF THE ROSSMANN FOLD
108, 4cakB, 0.7811, 2.42, 0.124, 680, 210, THREE-DIMENSIONAL RECONSTRUCTION OF INTACT HUMAN INTEGRIN ALPHAIIBBETA3 IN A PHOSPHOLIPID BILAYER NANODISC
109, 2ww8A, 0.6396, 4.45, 0.121, 815, 214, STRUCTURE OF THE PILUS ADHESIN (RRGA) FROM STREPTOCOCCUS PNEUMONIAE
110, 3txaA, 0.6344, 4.50, 0.103, 583, 214, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
111, 3tvyA, 0.6309, 4.33, 0.100, 365, 209, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
112, 6fvwCA, 0.6166, 2.62, 0.103, 197, 174, struct.pdbx_descriptor              
113, 6j30RA, 0.6138, 2.93, 0.113, 197, 177, struct.pdbx_descriptor              
114, 6j2nRA, 0.6131, 2.94, 0.107, 197, 177, struct.pdbx_descriptor              
115, 6j2cRA, 0.6131, 2.93, 0.113, 197, 177, struct.pdbx_descriptor              
116, 6fvvCA, 0.6117, 2.79, 0.103, 197, 175, struct.pdbx_descriptor              
117, 5mpcIA, 0.6102, 2.78, 0.103, 197, 174, 
118, 4cn9B, 0.6088, 3.10, 0.136, 396, 177, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS WITH ZINC OCCUPIED MIDAS MOTIF
119, 6fvuCA, 0.6082, 2.82, 0.103, 197, 174, struct.pdbx_descriptor              
120, 4cnbB, 0.6080, 3.14, 0.136, 391, 177, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS - CRYSTAL FORM 2
121, 4cn9A, 0.6075, 3.12, 0.141, 397, 177, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS WITH ZINC OCCUPIED MIDAS MOTIF
122, 6fvyCA, 0.6073, 2.84, 0.103, 197, 174, struct.pdbx_descriptor              
123, 4cnbA, 0.6073, 3.15, 0.136, 387, 177, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS - CRYSTAL FORM 2
124, 6fvxCA, 0.6065, 2.84, 0.103, 197, 174, struct.pdbx_descriptor              
125, 4cn8A, 0.6065, 3.16, 0.136, 392, 177, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS
126, 5mpeW, 0.6060, 2.96, 0.108, 197, 176, 26S PROTEASOME IN PRESENCE OF ATP (S2)
127, 4cr4W, 0.6057, 2.98, 0.114, 197, 176, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
128, 1sq0A, 0.6052, 3.24, 0.118, 198, 178, CRYSTAL STRUCTURE OF THE COMPLEX OF THE WILD-TYPE VON WILLEBRAND FACTOR A1 DOMAIN AND GLYCOPROTEIN IB ALPHA AT 2.6 ANGSTROM RESOLUTION
129, 1fnsA, 0.6026, 3.19, 0.113, 196, 177, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4
130, 6epdW, 0.6024, 2.89, 0.109, 195, 174, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
131, 5mpbIA, 0.6024, 3.04, 0.108, 197, 176, 
132, 3q3gL, 0.6024, 2.84, 0.127, 189, 173, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
133, 3q3gG, 0.6024, 2.86, 0.127, 189, 173, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
134, 3q3gE, 0.6014, 2.90, 0.132, 189, 174, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
135, 3jcpFA, 0.6013, 3.08, 0.108, 197, 176, 
136, 1na5A, 0.6011, 2.93, 0.120, 195, 175, INTEGRIN ALPHA M I DOMAIN
137, 1oakA, 0.6010, 3.10, 0.114, 196, 176, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
138, 4cr2W, 0.6008, 3.18, 0.097, 197, 175, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
139, 3q3gI, 0.6006, 2.89, 0.127, 189, 173, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
140, 6fvtCA, 0.5998, 2.86, 0.103, 197, 174, struct.pdbx_descriptor              
141, 3jcoFA, 0.5996, 3.14, 0.113, 197, 177, 
142, 3hxoA, 0.5995, 3.14, 0.114, 199, 176, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH DNA APTAMER ARC1172 AN INHIBITOR OF VWF-PLATELET BINDING
143, 4c2aA, 0.5992, 3.18, 0.114, 202, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH R1306Q AND I1309V MUTATIONS IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
144, 5l4kW, 0.5990, 3.08, 0.098, 196, 174, THE HUMAN 26S PROTEASOME LID
145, 1ijbA, 0.5987, 3.26, 0.113, 202, 177, THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN
146, 1uexC, 0.5986, 3.26, 0.113, 202, 177, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR A1 DOMAIN COMPLEXED WITH SNAKE VENOM BITISCETIN
147, 5es4A, 0.5985, 3.06, 0.131, 1080, 175, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
148, 4c2bC, 0.5984, 3.15, 0.114, 199, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
149, 1m10A, 0.5982, 3.16, 0.108, 199, 176, CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB ALPHA AND THE VON WILLEBRAND FACTOR A1 DOMAIN
150, 4c2bG, 0.5981, 3.17, 0.119, 197, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
151, 3hxqA, 0.5981, 3.16, 0.114, 201, 176, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH DNA APTAMER ARC1172 AN INHIBITOR OF VWF-PLATELET BINDING
152, 1auqA, 0.5981, 3.29, 0.119, 208, 177, A1 DOMAIN OF VON WILLEBRAND FACTOR
153, 1mf7A, 0.5978, 2.97, 0.132, 194, 174, INTEGRIN ALPHA M I DOMAIN
154, 4c2bA, 0.5977, 3.30, 0.113, 199, 177, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
155, 1u0oC, 0.5977, 3.16, 0.114, 195, 176, THE MOUSE VON WILLEBRAND FACTOR A1-BOTROCETIN COMPLEX
156, 1u0nA, 0.5976, 3.26, 0.119, 207, 177, THE TERNARY VON WILLEBRAND FACTOR A1-GLYCOPROTEIN IBALPHA- BOTROCETIN COMPLEX
157, 5bv8A, 0.5974, 3.18, 0.108, 209, 176, G1324S MUTATION IN VON WILLEBRAND FACTOR A1 DOMAIN
158, 5a5bW, 0.5973, 3.01, 0.114, 197, 175, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
159, 4cr3W, 0.5973, 3.01, 0.114, 197, 175, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
160, 1n3yA, 0.5971, 2.91, 0.122, 189, 172, CRYSTAL STRUCTURE OF THE ALPHA-X BETA2 INTEGRIN I DOMAIN
161, 1ijkA, 0.5971, 3.08, 0.120, 199, 175, THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN- BOTROCETIN COMPLEX
162, 4wfqA, 0.5963, 2.71, 0.083, 192, 169, CRYSTAL STRUCTURE OF TFIIH SUBUNIT
163, 3tw0A, 0.5962, 4.48, 0.106, 361, 198, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
164, 4f1jA, 0.5961, 3.09, 0.099, 200, 171, CRYSTAL STRUCTURE OF THE MG2+ LOADED VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
165, 4f1kA, 0.5960, 3.09, 0.099, 200, 171, CRYSTAL STRUCTURE OF THE MG2+ FREE VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
166, 3k71G, 0.5959, 3.04, 0.132, 1082, 174, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
167, 4c29B, 0.5957, 3.17, 0.114, 201, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION
168, 4c29A, 0.5956, 3.18, 0.114, 201, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION
169, 3k6sA, 0.5956, 3.05, 0.132, 1082, 174, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
170, 5mpdW, 0.5954, 3.06, 0.108, 197, 176, 26S PROTEASOME IN PRESENCE OF ATP (S1)
171, 4c2bE, 0.5953, 3.22, 0.114, 199, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
172, 4f1jB, 0.5949, 3.06, 0.088, 200, 170, CRYSTAL STRUCTURE OF THE MG2+ LOADED VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
173, 4f1kB, 0.5946, 2.94, 0.089, 200, 169, CRYSTAL STRUCTURE OF THE MG2+ FREE VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
174, 3qa3G, 0.5946, 3.03, 0.126, 187, 174, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
175, 6gym4, 0.5945, 3.52, 0.104, 297, 183, STRUCTURE OF A YEAST CLOSED COMPLEX WITH DISTORTED DNA (CCDIST) 
176, 5ln1A, 0.5941, 3.00, 0.105, 188, 172, STRUCTURE OF UBIQUITYLATED-RPN10 FROM YEAST;
177, 5gjrP, 0.5940, 3.07, 0.109, 193, 174, 
178, 5gjrJB, 0.5940, 3.07, 0.109, 193, 174, 
179, 1bhq2, 0.5940, 3.02, 0.127, 189, 173, MAC-1 I DOMAIN CADMIUM COMPLEX
180, 5gjqW, 0.5938, 3.07, 0.109, 193, 174, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
181, 1idn2, 0.5937, 3.04, 0.116, 189, 173, MAC-1 I DOMAIN METAL FREE
182, 3tw0B, 0.5934, 4.66, 0.108, 361, 203, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
183, 1bho1, 0.5933, 3.04, 0.127, 189, 173, MAC-1 I DOMAIN MAGNESIUM COMPLEX
184, 5wvkRA, 0.5932, 3.26, 0.113, 197, 177, 
185, 3tw0C, 0.5932, 4.69, 0.127, 360, 205, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
186, 1bho2, 0.5927, 3.06, 0.116, 189, 173, MAC-1 I DOMAIN MAGNESIUM COMPLEX
187, 1jlmA, 0.5925, 2.96, 0.126, 187, 174, I-DOMAIN FROM INTEGRIN CR3 MN2+ BOUND
188, 1bhq1, 0.5924, 3.05, 0.127, 189, 173, MAC-1 I DOMAIN CADMIUM COMPLEX
189, 6mskH, 0.5923, 3.06, 0.127, 191, 173, struct.pdbx_descriptor               26S proteasome  
190, 4hqkA, 0.5920, 3.08, 0.082, 200, 170, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP P4212 FORM
191, 6o9m6, 0.5917, 2.87, 0.129, 385, 171, STRUCTURE OF THE HUMAN APO TFIIH 
192, 1idn1, 0.5915, 3.07, 0.127, 189, 173, MAC-1 I DOMAIN METAL FREE
193, 6j2qRA, 0.5914, 3.25, 0.098, 197, 174, struct.pdbx_descriptor              
194, 6nmiE, 0.5913, 2.92, 0.135, 366, 171, CRYO-EM STRUCTURE OF THE HUMAN TFIIH CORE COMPLEX 
195, 3tw0D, 0.5912, 4.57, 0.109, 357, 202, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
196, 5oqm4, 0.5910, 3.54, 0.104, 297, 182, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH AND CORE MEDIATOR 
197, 5oqj4, 0.5910, 3.54, 0.104, 297, 182, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH 
198, 5wviT, 0.5903, 3.22, 0.086, 197, 174, 
199, 3qa3I, 0.5901, 2.94, 0.128, 185, 172, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
200, 4hqkB, 0.5898, 3.05, 0.083, 199, 169, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP P4212 FORM
201, 4igiA, 0.5883, 3.13, 0.121, 197, 173, CRYSTAL STRUCTURE OF THE COLLAGEN VI ALPHA3 N5 DOMAIN
202, 5nusA, 0.5880, 3.07, 0.075, 210, 173, STRUCTURE OF A MINIMAL COMPLEX BETWEEN P44 AND P34 FROM CHAETOMIUM THERMOPHILUM
203, 3qa3E, 0.5879, 3.17, 0.133, 186, 173, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
204, 6epeW, 0.5878, 2.97, 0.105, 195, 172, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
205, 6ro4D, 0.5876, 3.14, 0.133, 280, 173, STRUCTURE OF THE CORE TFIIH-XPA-DNA COMPLEX 
206, 6msjH, 0.5876, 3.04, 0.128, 191, 172, struct.pdbx_descriptor               26S proteasome  
207, 3qa3L, 0.5874, 3.05, 0.129, 185, 171, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
208, 4ihkA, 0.5873, 3.16, 0.127, 193, 173, CRYSTAL STRUCTURE OF THE COLLAGEN VI ALPHA3 N5 DOMAIN R1061Q
209, 5vfsV, 0.5863, 2.94, 0.100, 191, 170, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
210, 5vgzb, 0.5853, 3.13, 0.105, 191, 172, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
211, 6mseH, 0.5851, 2.96, 0.100, 191, 170, struct.pdbx_descriptor               26S proteasome  
212, 6o9l6, 0.5850, 2.94, 0.124, 385, 170, HUMAN HOLO-PIC IN THE CLOSED STATE 
213, 5kyuA, 0.5848, 3.86, 0.088, 716, 181, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE2 COMPLEX
214, 5kynB, 0.5847, 3.76, 0.078, 719, 180, STRUCTURE OF SEC23 AND TANGO1 COMPLEX
215, 6msgH, 0.5846, 3.08, 0.128, 191, 172, struct.pdbx_descriptor               26S proteasome  
216, 5kyxA, 0.5846, 3.78, 0.089, 716, 180, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE1 COMPLEX
217, 5ivw0, 0.5846, 2.83, 0.108, 188, 167, HUMAN CORE TFIIH BOUND TO DNA WITHIN THE PIC
218, 4pn7A, 0.5845, 3.23, 0.086, 209, 175, CRYSTAL STRUCTURE OF THE TFIIH P34 N-TERMINAL DOMAIN
219, 5kyyA, 0.5844, 3.74, 0.078, 716, 180, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE4 COMPLEX
220, 5iy80, 0.5844, 3.18, 0.134, 188, 172, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE
221, 5iy70, 0.5844, 3.18, 0.134, 188, 172, HUMAN HOLO-PIC IN THE OPEN STATE
222, 5iy60, 0.5844, 3.18, 0.134, 188, 172, HUMAN HOLO-PIC IN THE CLOSED STATE
223, 5iy90, 0.5843, 3.18, 0.134, 188, 172, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE (NO IIS)
224, 5oqm6, 0.5842, 3.24, 0.103, 335, 175, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH AND CORE MEDIATOR 
225, 5oqj6, 0.5842, 3.24, 0.103, 335, 175, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH 
226, 5of4E, 0.5842, 2.81, 0.119, 184, 168, THE CRYO-EM STRUCTURE OF HUMAN TFIIH
227, 5vfqV, 0.5840, 2.98, 0.106, 191, 170, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
228, 5kywA, 0.5839, 3.75, 0.078, 714, 180, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE3 COMPLEX
229, 1m2oA, 0.5838, 3.78, 0.106, 718, 180, CRYSTAL STRUCTURE OF THE SEC23-SAR1 COMPLEX
230, 1m2oC, 0.5837, 3.88, 0.105, 718, 181, CRYSTAL STRUCTURE OF THE SEC23-SAR1 COMPLEX
231, 6j2xRA, 0.5834, 3.30, 0.104, 197, 173, struct.pdbx_descriptor              
232, 5vniA, 0.5833, 3.83, 0.083, 707, 180, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FA SORTING MOTIF
233, 6mshH, 0.5832, 3.10, 0.128, 191, 172, struct.pdbx_descriptor               26S proteasome  
234, 6gniA, 0.5832, 3.78, 0.106, 733, 180, CRYO-TOMOGRAPHY AND SUBTOMOGRAM AVERAGING OF SAR1-SEC23-SEC24 - FITTED MODEL. 
235, 4bziG, 0.5832, 3.78, 0.106, 733, 180, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
236, 4bziD, 0.5832, 3.78, 0.106, 733, 180, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
237, 4bziA, 0.5832, 3.78, 0.106, 733, 180, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
238, 2qtvA, 0.5832, 3.78, 0.106, 733, 180, STRUCTURE OF SEC23-SAR1 COMPLEXED WITH THE ACTIVE FRAGMENT OF SEC31
239, 5vnmA, 0.5831, 3.90, 0.088, 698, 181, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (15MM SOAKING)
240, 5obzA, 0.5831, 3.36, 0.091, 200, 176, LOW RESOLUTION STRUCTURE OF THE P34CT/P44CT MINIMAL COMPLEX
241, 5vnlA, 0.5827, 3.82, 0.089, 699, 180, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (1MM SOAKING)
242, 5vnhA, 0.5826, 3.81, 0.078, 707, 180, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL SV SORTING MOTIF
243, 5vnnA, 0.5825, 3.83, 0.089, 699, 180, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (50MM SOAKING)
244, 5vneA, 0.5823, 3.81, 0.078, 708, 180, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH EMP24 SORTING MOTIF
245, 5y58E, 0.5822, 4.17, 0.095, 548, 189, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
246, 5y58A, 0.5822, 4.19, 0.095, 548, 189, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
247, 6o9l4, 0.5821, 3.40, 0.101, 295, 179, HUMAN HOLO-PIC IN THE CLOSED STATE 
248, 5vftb, 0.5821, 2.96, 0.106, 191, 170, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
249, 5t0hb, 0.5821, 2.96, 0.106, 191, 170, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
250, 3efoA, 0.5820, 3.77, 0.078, 716, 180, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF SYNTAXIN 5
251, 5vnoA, 0.5819, 3.80, 0.078, 703, 180, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22
252, 3eg9A, 0.5819, 3.78, 0.078, 726, 180, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF MEMBRIN
253, 3ppvA, 0.5818, 2.91, 0.102, 184, 167, CRYSTAL STRUCTURE OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
254, 1m2vA, 0.5818, 3.76, 0.106, 705, 180, CRYSTAL STRUCTURE OF THE YEAST SEC23/24 HETERODIMER
255, 5iy73, 0.5817, 3.22, 0.098, 193, 174, HUMAN HOLO-PIC IN THE OPEN STATE
256, 5iy63, 0.5817, 3.22, 0.098, 193, 174, HUMAN HOLO-PIC IN THE CLOSED STATE
257, 6gym6, 0.5816, 3.27, 0.103, 335, 175, STRUCTURE OF A YEAST CLOSED COMPLEX WITH DISTORTED DNA (CCDIST) 
258, 5iy93, 0.5816, 3.22, 0.098, 193, 174, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE (NO IIS)
259, 5iy83, 0.5816, 3.22, 0.098, 193, 174, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE
260, 3egxA, 0.5816, 3.78, 0.078, 708, 180, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22B AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF THE SNARE PROTEIN BET1
261, 5vnjA, 0.5815, 3.79, 0.078, 697, 180, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FF SORTING MOTIF (ERGIC-53)
262, 5vngA, 0.5815, 3.81, 0.078, 696, 180, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL II SORTING MOTIF
263, 2nutA, 0.5814, 3.79, 0.078, 708, 180, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
264, 5y58C, 0.5813, 4.18, 0.101, 548, 189, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
265, 5ivw3, 0.5811, 3.22, 0.098, 193, 174, HUMAN CORE TFIIH BOUND TO DNA WITHIN THE PIC
266, 3egdA, 0.5811, 3.79, 0.078, 711, 180, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22 AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF VESICULAR STOMATITIS VIRUS GLYCOPROTEIN
267, 5t0gb, 0.5809, 3.00, 0.100, 191, 170, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
268, 5t0cNA, 0.5809, 3.00, 0.100, 191, 170, 
269, 5t0cH, 0.5809, 3.00, 0.100, 191, 170, 
270, 5kynA, 0.5808, 3.81, 0.078, 730, 180, STRUCTURE OF SEC23 AND TANGO1 COMPLEX
271, 2nupA, 0.5808, 3.79, 0.078, 699, 180, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
272, 5vnkA, 0.5807, 3.81, 0.078, 708, 180, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL LL SORTING MOTIF
273, 5vnfA, 0.5807, 3.82, 0.078, 707, 180, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL VV SORTING MOTIF
274, 5vhfb, 0.5806, 3.22, 0.105, 191, 172, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
275, 3ppxA, 0.5805, 2.88, 0.102, 184, 167, CRYSTAL STRUCTURE OF THE N1602A MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
276, 3ppwA, 0.5805, 2.88, 0.102, 184, 167, CRYSTAL STRUCTURE OF THE D1596A MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
277, 5vhhb, 0.5804, 3.22, 0.105, 191, 172, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
278, 3ppyA, 0.5801, 2.89, 0.102, 187, 167, CRYSTAL STRUCTURE OF THE D1596A/N1602A DOUBLE MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
279, 6nmiF, 0.5790, 3.60, 0.117, 263, 179, CRYO-EM STRUCTURE OF THE HUMAN TFIIH CORE COMPLEX 
280, 5vhib, 0.5789, 3.27, 0.110, 191, 172, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
281, 5vhsb, 0.5780, 3.26, 0.105, 191, 172, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
282, 6ergA, 0.5779, 3.97, 0.098, 501, 183, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
283, 6gniE, 0.5776, 3.50, 0.120, 735, 175, CRYO-TOMOGRAPHY AND SUBTOMOGRAM AVERAGING OF SAR1-SEC23-SEC24 - FITTED MODEL. 
284, 4bziM, 0.5776, 3.50, 0.120, 735, 175, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
285, 4bziL, 0.5776, 3.50, 0.120, 735, 175, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
286, 4bziE, 0.5776, 3.50, 0.120, 735, 175, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
287, 1m2vB, 0.5776, 3.50, 0.120, 748, 175, CRYSTAL STRUCTURE OF THE YEAST SEC23/24 HETERODIMER
288, 5vfpU, 0.5775, 3.04, 0.100, 191, 170, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
289, 2x5nA, 0.5774, 3.06, 0.095, 188, 169, CRYSTAL STRUCTURE OF THE SPRPN10 VWA DOMAIN
290, 1idoA, 0.5774, 3.00, 0.142, 184, 169, I-DOMAIN FROM INTEGRIN CR3 MG2+ BOUND
291, 6epcW, 0.5773, 3.26, 0.115, 195, 174, GROUND STATE 26S PROTEASOME (GS2)
292, 6ergD, 0.5771, 4.02, 0.092, 503, 184, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
293, 6bxbA, 0.5767, 3.00, 0.137, 463, 168, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN P33 
294, 6bxjA, 0.5766, 2.97, 0.137, 619, 168, STRUCTURE OF A SINGLE-CHAIN BETA3 INTEGRIN 
295, 6o9m4, 0.5765, 3.62, 0.111, 295, 180, STRUCTURE OF THE HUMAN APO TFIIH 
296, 4xw2A, 0.5764, 3.14, 0.147, 184, 170, STRUCTURAL BASIS FOR SIMVASTATIN COMPETITIVE ANTAGONISM OF COMPLEMENT RECEPTOR 3
297, 1m1uA, 0.5763, 3.05, 0.147, 184, 170, AN ISOLEUCINE-BASED ALLOSTERIC SWITCH CONTROLS AFFINITY AND SHAPE SHIFTING IN INTEGRIN CD11B A-DOMAIN
298, 6epfW, 0.5759, 3.36, 0.109, 195, 175, GROUND STATE 26S PROTEASOME (GS1)
299, 5vfuH, 0.5758, 3.09, 0.100, 191, 170, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
300, 5t0ib, 0.5758, 3.09, 0.100, 191, 170, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
301, 1jeqA, 0.5758, 3.93, 0.104, 548, 183, CRYSTAL STRUCTURE OF THE KU HETERODIMER
302, 6msdH, 0.5756, 3.01, 0.100, 191, 170, struct.pdbx_descriptor               26S proteasome  
303, 6msbH, 0.5748, 3.05, 0.100, 191, 170, struct.pdbx_descriptor               26S proteasome  
304, 6bxfA, 0.5747, 3.03, 0.137, 463, 168, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN L33 
305, 1n9zA, 0.5745, 3.15, 0.141, 184, 170, INTEGRIN ALPHA M I DOMAIN MUTANT
306, 5t0jb, 0.5735, 3.12, 0.100, 191, 170, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
307, 5ln3W, 0.5733, 2.87, 0.115, 185, 165, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
308, 6ckbA, 0.5732, 3.04, 0.131, 464, 168, CRYSTAL STRUCTURE OF AN EXTENDED BETA3 INTEGRIN P33 
309, 1zonA, 0.5730, 2.92, 0.127, 181, 166, CD11A I-DOMAIN WITHOUT BOUND CATION
310, 6bxfB, 0.5727, 3.04, 0.137, 464, 168, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN L33 
311, 1pd1A, 0.5725, 4.02, 0.094, 735, 180, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE CONTAINING THE DXE CARGO SORTING SIGNAL OF YEAST SYS1 PROTEIN
312, 1pd0A, 0.5722, 4.02, 0.111, 734, 180, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE FROM THE SNARE PROTEIN SED5 (YEAST SYNTAXIN-5)
313, 6ro4E, 0.5718, 3.50, 0.120, 237, 175, STRUCTURE OF THE CORE TFIIH-XPA-DNA COMPLEX 
314, 3egdB, 0.5717, 3.67, 0.063, 731, 174, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22 AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF VESICULAR STOMATITIS VIRUS GLYCOPROTEIN
315, 5vnjB, 0.5714, 3.66, 0.069, 731, 174, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FF SORTING MOTIF (ERGIC-53)
316, 5of4F, 0.5714, 3.49, 0.115, 205, 174, THE CRYO-EM STRUCTURE OF HUMAN TFIIH
317, 2nupB, 0.5713, 3.67, 0.069, 731, 174, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
318, 1pcxA, 0.5713, 4.03, 0.111, 745, 180, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE FROM THE SNARE PROTEIN BET1
319, 5vnmB, 0.5710, 3.68, 0.069, 731, 174, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (15MM SOAKING)
320, 5vnlB, 0.5710, 3.68, 0.063, 731, 174, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (1MM SOAKING)
321, 6erhC, 0.5709, 4.03, 0.110, 493, 182, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
322, 6bxbB, 0.5708, 3.06, 0.125, 465, 168, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN P33 
323, 5vnhB, 0.5708, 3.67, 0.069, 729, 174, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL SV SORTING MOTIF
324, 5vneB, 0.5708, 3.67, 0.063, 729, 174, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH EMP24 SORTING MOTIF
325, 3egxB, 0.5707, 3.68, 0.069, 729, 174, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22B AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF THE SNARE PROTEIN BET1
326, 2nutB, 0.5707, 3.67, 0.063, 729, 174, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
327, 5vnnB, 0.5706, 3.67, 0.063, 731, 174, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (50MM SOAKING)
328, 5vnfB, 0.5706, 3.68, 0.063, 729, 174, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL VV SORTING MOTIF
329, 5vniB, 0.5705, 3.68, 0.063, 727, 174, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FA SORTING MOTIF
330, 5vnoB, 0.5702, 3.69, 0.063, 731, 174, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22
331, 5vngB, 0.5702, 3.68, 0.063, 728, 174, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL II SORTING MOTIF
332, 5vnkB, 0.5701, 3.67, 0.063, 729, 174, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL LL SORTING MOTIF
333, 1jeyB, 0.5700, 3.97, 0.102, 530, 177, CRYSTAL STRUCTURE OF THE KU HETERODIMER BOUND TO DNA
334, 6erfE, 0.5698, 3.99, 0.110, 497, 181, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
335, 6ckbB, 0.5697, 3.10, 0.125, 465, 168, CRYSTAL STRUCTURE OF AN EXTENDED BETA3 INTEGRIN P33 
336, 2odpA, 0.5695, 3.86, 0.090, 490, 178, COMPLEMENT COMPONENT C2A THE CATALYTIC FRAGMENT OF C3- AND C5- CONVERTASE OF HUMAN COMPLEMENT
337, 2i6qA, 0.5695, 3.86, 0.090, 503, 178, COMPLEMENT COMPONENT C2A
338, 2odqA, 0.5692, 3.88, 0.090, 492, 178, COMPLEMENT COMPONENT C2A THE CATALYTIC FRAGMENT OF C3- AND C5- CONVERTASE OF HUMAN COMPLEMENT
339, 3zqkC, 0.5689, 2.87, 0.117, 178, 163, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
340, 1jeyA, 0.5689, 4.08, 0.109, 493, 183, CRYSTAL STRUCTURE OF THE KU HETERODIMER BOUND TO DNA
341, 6erfB, 0.5686, 3.89, 0.102, 521, 176, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
342, 6erfH, 0.5684, 3.83, 0.103, 526, 175, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
343, 6erfD, 0.5683, 3.90, 0.102, 520, 176, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
344, 3f78C, 0.5683, 3.07, 0.132, 180, 167, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
345, 6erfF, 0.5681, 3.88, 0.102, 526, 176, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
346, 3f74C, 0.5681, 3.09, 0.132, 180, 167, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
347, 4nehA, 0.5679, 3.27, 0.137, 1084, 168, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
348, 3zqkB, 0.5677, 2.82, 0.117, 178, 162, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
349, 6erfC, 0.5671, 3.88, 0.106, 500, 179, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
350, 5gjwF, 0.5668, 3.22, 0.124, 941, 169, STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX FOR CLASSII MAP
351, 4m76B, 0.5668, 2.98, 0.133, 179, 166, INTEGRIN I DOMAIN OF COMPLEMENT RECEPTOR 3 IN COMPLEX WITH C3D
352, 5e6sA, 0.5665, 3.45, 0.118, 578, 169, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
353, 3zqkA, 0.5664, 2.86, 0.123, 181, 162, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
354, 5o85C, 0.5662, 3.38, 0.093, 198, 172, P34-P44 COMPLEX
355, 3ibsA, 0.5662, 3.28, 0.120, 200, 167, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN BATB FROM BACTEROIDES THETAIOTAOMICRON
356, 1jeqB, 0.5662, 3.74, 0.103, 520, 174, CRYSTAL STRUCTURE OF THE KU HETERODIMER
357, 3ibsB, 0.5661, 3.29, 0.120, 199, 167, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN BATB FROM BACTEROIDES THETAIOTAOMICRON
358, 5e6sE, 0.5660, 3.41, 0.137, 580, 168, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
359, 5e6uA, 0.5657, 3.20, 0.125, 583, 168, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
360, 5gjvF, 0.5655, 3.08, 0.108, 941, 166, STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT NEAR ATOMIC RESOLUTION
361, 3jbrF, 0.5655, 3.21, 0.101, 872, 168, CRYO-EM STRUCTURE OF THE RABBIT VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT 4.2 ANGSTROM
362, 6erfA, 0.5652, 3.86, 0.107, 493, 178, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
363, 2i6sA, 0.5650, 3.64, 0.104, 497, 173, COMPLEMENT COMPONENT C2A
364, 4nenA, 0.5647, 3.35, 0.131, 1063, 168, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
365, 3eh1A, 0.5644, 3.74, 0.075, 737, 174, CRYSTAL STRUCTURE OF THE HUMAN COPII-COAT PROTEIN SEC24B
366, 3f74A, 0.5641, 3.06, 0.139, 180, 165, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
367, 1dgqA, 0.5640, 3.31, 0.132, 188, 167, NMR SOLUTION STRUCTURE OF THE INSERTED DOMAIN OF HUMAN LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1
368, 5e6rA, 0.5638, 3.22, 0.125, 581, 168, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
369, 3f78B, 0.5637, 3.19, 0.132, 180, 167, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
370, 6erfG, 0.5633, 4.00, 0.112, 495, 179, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
371, 6erhA, 0.5629, 4.01, 0.112, 490, 179, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
372, 3f74B, 0.5629, 3.14, 0.145, 180, 166, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
373, 3gxbA, 0.5627, 3.08, 0.104, 177, 164, CRYSTAL STRUCTURE OF VWF A2 DOMAIN
374, 3f78A, 0.5626, 3.08, 0.133, 180, 165, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
375, 3gxbB, 0.5625, 3.07, 0.104, 177, 164, CRYSTAL STRUCTURE OF VWF A2 DOMAIN
376, 6cesD, 0.5623, 4.10, 0.066, 901, 181, CRYO-EM STRUCTURE OF GATOR1-RAG
377, 5y3rB, 0.5612, 3.81, 0.091, 526, 175, CRYO-EM STRUCTURE OF HUMAN DNA-PK HOLOENZYME
378, 5o85A, 0.5611, 3.43, 0.111, 190, 171, P34-P44 COMPLEX
379, 6cetD, 0.5609, 4.13, 0.056, 901, 180, CRYO-EM STRUCTURE OF GATOR1
380, 5e6sC, 0.5607, 3.17, 0.133, 578, 166, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
381, 4okrB, 0.5606, 2.88, 0.125, 236, 160, STRUCTURES OF TOXOPLASMA GONDII MIC2
382, 2x31C, 0.5602, 3.08, 0.103, 187, 165, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
383, 2x31D, 0.5594, 3.07, 0.104, 187, 164, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
384, 4hqoB, 0.5586, 3.44, 0.114, 260, 166, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX TRAP PROTEIN
385, 1mjnA, 0.5579, 3.00, 0.154, 179, 162, CRYSTAL STRUCTURE OF THE INTERMEDIATE AFFINITY AL I DOMAIN MUTANT
386, 1shtX, 0.5576, 3.51, 0.137, 177, 168, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR
387, 4okuB, 0.5575, 2.85, 0.126, 241, 159, STRUCTURE OF TOXOPLASMA GONDII PROMIC2
388, 2o7nA, 0.5574, 3.40, 0.114, 180, 166, CD11A (LFA1) I-DOMAIN COMPLEXED WITH 7A-[(4-CYANOPHENYL) METHYL]-6-(35-DICHLOROPHENYL)-5-OXO-2357A-TETRAHYDRO- 1H-PYRROLO[12-A]PYRROLE-7-CARBONITRILE
389, 2x31E, 0.5572, 3.15, 0.104, 187, 164, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
390, 2x31B, 0.5561, 3.11, 0.110, 187, 164, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
391, 1shuX, 0.5561, 3.53, 0.137, 181, 168, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR
392, 6adrR, 0.5552, 3.60, 0.113, 185, 168, ANTHRAX TOXIN RECEPTOR 1-BOUND THE SENECA VALLEY VIRUS IN NEUTRAL CONDITIONS 
393, 4fx5A, 0.5552, 3.41, 0.130, 415, 169, VON WILLEBRAND FACTOR TYPE A FROM CATENULISPORA ACIDIPHILA
394, 2x31A, 0.5552, 3.20, 0.121, 187, 165, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
395, 6ergE, 0.5550, 3.72, 0.101, 536, 169, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
396, 3m6fA, 0.5550, 3.42, 0.120, 180, 166, CD11A I-DOMAIN COMPLEXED WITH 6-((5S9R)-9-(4-CYANOPHENYL)-3-(35- DICHLOROPHENYL)-1-METHYL-24-DIOXO-137- TRIAZASPIRO[4.4]NON-7-YL) NICOTINIC ACID
397, 4hqoA, 0.5548, 3.53, 0.108, 257, 166, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX TRAP PROTEIN
398, 4hqnB, 0.5547, 3.61, 0.138, 256, 167, CRYSTAL STRUCTURE OF MANGANESE-LOADED PLASMODIUM VIVAX TRAP PROTEIN
399, 2x31F, 0.5547, 3.13, 0.104, 187, 164, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
400, 1tzno, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
401, 1tznm, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
402, 1tznl, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
403, 1tznk, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
404, 1tznj, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
405, 1tzni, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
406, 1tznh, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
407, 1tzng, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
408, 1tznf, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
409, 1tzne, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
410, 1tznd, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
411, 1tznc, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
412, 1tznb, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
413, 1tzna, 0.5547, 3.64, 0.136, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
414, 6ergB, 0.5544, 3.74, 0.118, 531, 170, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
415, 2icaA, 0.5544, 3.35, 0.122, 179, 164, CD11A (LFA1) I-DOMAIN COMPLEXED WITH BMS-587101 AKA 5-[(5S 9R)-9-(4-CYANOPHENYL)-3-(35-DICHLOROPHENYL)-1-METHYL-24- DIOXO-137-TRIAZASPIRO [4.4]NON-7-YL]METHYL]-3- THIOPHENECARBOXYLICACID
416, 4hqlB, 0.5543, 3.62, 0.132, 256, 167, CRYSTAL STRUCTURE OF MAGNESIUM-LOADED PLASMODIUM VIVAX TRAP PROTEIN
417, 6erhD, 0.5542, 3.74, 0.101, 535, 169, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
418, 4hqfA, 0.5542, 3.77, 0.082, 200, 171, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP I4 FORM
419, 3eobI, 0.5538, 3.14, 0.142, 179, 162, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
420, 3hi6A, 0.5535, 3.34, 0.127, 180, 165, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
421, 3eoaI, 0.5535, 3.25, 0.128, 179, 164, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
422, 1xddA, 0.5534, 3.31, 0.140, 182, 164, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION
423, 4jduA, 0.5532, 2.96, 0.075, 193, 160, THE CRYSTAL STRUCTURE OF AN AEROTOLERANCE-RELATED MEMBRANE PROTEIN FROM BACTEROIDES FRAGILIS NCTC 9343 WITH MULTIPLE MUTATIONS TO SERINES.
424, 4hqnA, 0.5526, 3.56, 0.108, 254, 166, CRYSTAL STRUCTURE OF MANGANESE-LOADED PLASMODIUM VIVAX TRAP PROTEIN
425, 4hqlA, 0.5526, 3.56, 0.108, 254, 166, CRYSTAL STRUCTURE OF MAGNESIUM-LOADED PLASMODIUM VIVAX TRAP PROTEIN
426, 3eobJ, 0.5525, 3.26, 0.128, 179, 164, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
427, 1xuoA, 0.5525, 3.38, 0.128, 181, 164, X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 14-DIAZEPANE- 25-DIONE INHIBITOR AT 1.8A RESOLUTION
428, 6admR, 0.5524, 3.73, 0.107, 185, 169, ANTHRAX TOXIN RECEPTOR 1-BOUND FULL PARTICLES OF SENECA VALLEY VIRUS IN ACIDIC CONDITIONS 
429, 3hi6B, 0.5524, 3.25, 0.134, 180, 164, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
430, 5m6wL, 0.5522, 4.05, 0.114, 505, 175, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
431, 6erhB, 0.5520, 3.90, 0.117, 534, 171, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
432, 5vfrb, 0.5519, 3.30, 0.101, 191, 169, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
433, 3n2nD, 0.5517, 3.66, 0.107, 185, 168, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
434, 3n2nF, 0.5516, 3.66, 0.107, 185, 168, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
435, 3eoaJ, 0.5515, 3.20, 0.142, 179, 162, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
436, 1xddB, 0.5515, 3.09, 0.137, 182, 160, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION
437, 3n2nA, 0.5513, 3.68, 0.107, 185, 168, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
438, 3bqnB, 0.5513, 3.32, 0.122, 182, 164, LFA-1 I DOMAIN BOUND TO INHIBITORS
439, 1cqpA, 0.5512, 3.20, 0.142, 182, 162, CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION
440, 1xuoB, 0.5511, 3.10, 0.136, 175, 162, X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 14-DIAZEPANE- 25-DIONE INHIBITOR AT 1.8A RESOLUTION
441, 4ixdA, 0.5508, 3.41, 0.127, 182, 165, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH IBE-667 AT 1.8A RESOLUTION
442, 1zopA, 0.5508, 3.33, 0.140, 183, 164, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
443, 1zooA, 0.5508, 3.33, 0.140, 183, 164, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
444, 1xdgA, 0.5508, 3.21, 0.142, 182, 162, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION
445, 1rs0A, 0.5508, 3.57, 0.124, 480, 170, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH DI-ISOPROPYL-PHOSPHATE (DIP)
446, 1lfaA, 0.5508, 3.41, 0.127, 183, 165, CD11A I-DOMAIN WITH BOUND MN++
447, 1rd4C, 0.5507, 3.23, 0.154, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
448, 1xdgB, 0.5506, 3.22, 0.142, 182, 162, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION
449, 1rd4D, 0.5506, 3.23, 0.154, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
450, 1rd4B, 0.5506, 3.23, 0.154, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
451, 1rd4A, 0.5506, 3.23, 0.154, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
452, 3e2mA, 0.5505, 3.15, 0.143, 182, 161, LFA-1 I DOMAIN BOUND TO INHIBITORS
453, 3bqmB, 0.5504, 3.22, 0.129, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
454, 1zopB, 0.5504, 3.34, 0.140, 183, 164, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
455, 1zooB, 0.5504, 3.34, 0.140, 183, 164, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
456, 1lfaB, 0.5504, 3.42, 0.127, 182, 165, CD11A I-DOMAIN WITH BOUND MN++
457, 1cqpB, 0.5504, 3.21, 0.142, 182, 162, CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION
458, 3bqnC, 0.5503, 3.25, 0.129, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
459, 3n2nB, 0.5501, 3.69, 0.107, 185, 168, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
460, 3bqmC, 0.5501, 3.25, 0.129, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
461, 3n2nE, 0.5496, 3.60, 0.108, 185, 167, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
462, 3n2nC, 0.5496, 3.70, 0.107, 185, 168, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
463, 5m6wJ, 0.5495, 3.82, 0.127, 505, 173, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
464, 3e2mB, 0.5494, 3.26, 0.129, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
465, 6cx1E, 0.5492, 3.79, 0.135, 182, 170, CRYO-EM STRUCTURE OF SENECA VALLEY VIRUS-ANTHRAX TOXIN RECEPTOR 1 COMPLEX 
466, 3tcxT, 0.5485, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
467, 3tcxD, 0.5485, 3.42, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
468, 3tcxZ, 0.5484, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
469, 3tcxN, 0.5484, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
470, 3tcxL, 0.5484, 3.42, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
471, 3tcxF, 0.5484, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
472, 3tcxB, 0.5484, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
473, 3tcxb, 0.5483, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
474, 3tcxX, 0.5483, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
475, 3tcxR, 0.5483, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
476, 3tcxP, 0.5483, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
477, 3tcxJ, 0.5483, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
478, 3tcxH, 0.5483, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
479, 2winL, 0.5483, 3.92, 0.121, 507, 174, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
480, 2winK, 0.5483, 3.92, 0.121, 507, 174, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
481, 2winJ, 0.5483, 3.92, 0.121, 507, 174, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
482, 2winI, 0.5483, 3.92, 0.121, 507, 174, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
483, 3tcxV, 0.5481, 3.43, 0.133, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
484, 1t6bY, 0.5477, 3.25, 0.117, 170, 162, CRYSTAL STRUCTURE OF B. ANTHRACIS PROTECTIVE ANTIGEN COMPLEXED WITH HUMAN ANTHRAX TOXIN RECEPTOR
485, 3hs0D, 0.5472, 3.68, 0.124, 699, 169, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
486, 2xwjK, 0.5463, 3.91, 0.128, 713, 172, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
487, 3hs0I, 0.5462, 3.71, 0.124, 704, 169, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
488, 2xwjJ, 0.5460, 3.93, 0.128, 713, 172, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
489, 2ok5A, 0.5460, 3.33, 0.110, 710, 163, HUMAN COMPLEMENT FACTOR B
490, 1rtkA, 0.5454, 3.85, 0.111, 486, 171, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH 4-GUANIDINOBENZOIC ACID
491, 2xwjI, 0.5453, 4.04, 0.127, 712, 173, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
492, 1rrkA, 0.5453, 3.85, 0.111, 480, 171, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B
493, 2xwbF, 0.5448, 4.03, 0.127, 714, 173, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
494, 5a8jA, 0.5440, 3.59, 0.127, 365, 166, CRYSTAL STRUCTURE OF THE ARNB PARALOG VWA2 FROM SULFOLOBUS ACIDOCALDARIUS
495, 2xwjL, 0.5439, 3.96, 0.128, 711, 172, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
496, 2xwbH, 0.5438, 3.95, 0.128, 711, 172, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
497, 4okuA, 0.5424, 3.12, 0.121, 240, 157, STRUCTURE OF TOXOPLASMA GONDII PROMIC2
498, 3hrzD, 0.5421, 3.80, 0.124, 693, 169, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
499, 4okrA, 0.5414, 3.10, 0.128, 235, 156, STRUCTURES OF TOXOPLASMA GONDII MIC2
500, 1t0pA, 0.5413, 3.18, 0.137, 174, 160, STRUCTURAL BASIS OF ICAM RECOGNITION BY INTEGRIN ALPAHLBETA2 REVEALED IN THE COMPLEX STRUCTURE OF BINDING DOMAINS OF ICAM-3 AND ALPHALBETA2 AT 1.65 A
501, 1mq9A, 0.5397, 3.17, 0.139, 173, 158, CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN WITH LIGAND MIMETIC CRYSTAL CONTACT
502, 1mqaA, 0.5393, 3.15, 0.133, 174, 158, CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN IN THE ABSENCE OF LIGAND OR METAL
503, 1mq8D, 0.5366, 3.52, 0.146, 177, 164, CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1
504, 1mq8B, 0.5365, 3.52, 0.146, 177, 164, CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1
505, 1q0pA, 0.5290, 3.47, 0.112, 192, 161, A DOMAIN OF FACTOR B
506, 3bn3A, 0.5223, 2.92, 0.139, 180, 151, CRYSTAL STRUCTURE OF ICAM-5 IN COMPLEX WITH AL I DOMAIN
507, 5y3rA, 0.5091, 4.46, 0.087, 493, 172, CRYO-EM STRUCTURE OF HUMAN DNA-PK HOLOENZYME
508, 1yvpA, 0.5076, 3.28, 0.085, 529, 153, RO AUTOANTIGEN COMPLEXED WITH RNAS
509, 1yvpB, 0.5059, 3.30, 0.085, 532, 153, RO AUTOANTIGEN COMPLEXED WITH RNAS
510, 2i91A, 0.5049, 3.44, 0.084, 520, 155, 60KDA RO AUTOANTIGEN IN COMPLEX WITH A FRAGMENT OF MISFOLDED RNA
511, 2i91B, 0.5048, 3.45, 0.084, 526, 155, 60KDA RO AUTOANTIGEN IN COMPLEX WITH A FRAGMENT OF MISFOLDED RNA
512, 1yvrA, 0.5040, 3.31, 0.085, 520, 153, RO AUTOANTIGEN
